Organogenesis Holdings Inc. SEC filings ORGO

Organogenesis Holdings Inc. has 673 filings in SEC EDGAR's recent list, going back to Dec 18, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Organogenesis Holdings Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Material agreement
Aug 6, 2026 Aug 6, 2026
424B5 Prospectus supplement Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 16, 2026 Jun 15, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Jun 15, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Officer or director change
Feb 23, 2026 Feb 18, 2026
8-K Current report
Material agreement
Dec 29, 2025 Dec 22, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 25, 2025 Sep 25, 2025
S-8 Employee stock plan registration Aug 7, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations
Aug 7, 2025 Aug 5, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 24, 2025 Jun 23, 2025
ARS Annual report to shareholders May 12, 2025 Dec 31, 2024
DEF 14A Proxy statement May 12, 2025 Jun 23, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
PRE 14A Preliminary proxy statement Apr 29, 2025 Jun 23, 2025
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Mar 27, 2025 Mar 27, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
424B3 Prospectus Dec 23, 2024 —
EFFECT Filing Dec 20, 2024 —
CORRESP Letter to the SEC Dec 20, 2024 —
UPLOAD Letter from the SEC Dec 20, 2024 —
S-3 Shelf registration Dec 19, 2024 —
8-K Current report
Material agreement
Dec 2, 2024 Nov 27, 2024
D Filing Nov 27, 2024 —
8-K Current report
Material agreement, Other events
Nov 22, 2024 Nov 18, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Nov 13, 2024 Nov 12, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
EFFECT Filing Aug 15, 2024 —
CORRESP Letter to the SEC Aug 13, 2024 —
UPLOAD Letter from the SEC Aug 13, 2024 —
S-3 Shelf registration Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 21, 2024 Jun 20, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 Jun 20, 2024
8-K Current report
Other events
Apr 3, 2024 Apr 3, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 13, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 10, 2023 May 10, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEF 14A Proxy statement May 1, 2023 —
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 1, 2023 Mar 1, 2023
S-8 Employee stock plan registration Dec 9, 2022 —
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 27, 2022 Jun 23, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
DEF 14A Proxy statement May 10, 2022 Jun 23, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
8-K Current report
Officer or director change
May 5, 2022 May 3, 2022
10-K/A Amended annual report Apr 29, 2022 Dec 31, 2021
PRE 14A Preliminary proxy statement Apr 29, 2022 Jun 23, 2022
8-K Current report
Other events
Apr 15, 2022 Apr 15, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
8-K Current report
Officer or director change
Feb 18, 2022 Feb 15, 2022
8-K Current report
Shareholder vote results
Dec 30, 2021 Dec 29, 2021
DEF 14A Proxy statement Nov 30, 2021 Dec 29, 2021
8-K Current report
Officer or director change
Nov 22, 2021 Nov 19, 2021
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
8-K Current report
Material agreement, Agreement ended
Aug 16, 2021 Aug 11, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Material agreement, Agreement ended, Results of operations, New debt, Regulation FD disclosure
Aug 9, 2021 Aug 6, 2021
8-K Current report
Listing notice, Officer or director change
May 27, 2021 May 24, 2021
8-K/A Amended current report
Results of operations
May 11, 2021 May 6, 2021
10-Q Quarterly report May 11, 2021 Mar 31, 2021
8-K Current report
Material agreement, Results of operations, Officer or director change
May 10, 2021 May 6, 2021
10-K/A Amended annual report Apr 30, 2021 Dec 31, 2020
8-K Current report
Material agreement
Apr 2, 2021 Mar 31, 2021
10-K Annual report Mar 16, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 16, 2021 Mar 16, 2021
8-K Current report
Officer or director change
Feb 16, 2021 Feb 16, 2021
8-K Current report
Results of operations
Jan 13, 2021 Jan 13, 2021
8-K Current report
Shareholder vote results
Dec 18, 2020 Dec 18, 2020
8-K Current report
Regulation FD disclosure
Dec 10, 2020 Dec 10, 2020
DEF 14A Proxy statement Nov 20, 2020 Dec 18, 2020
8-K Current report
Material agreement
Nov 18, 2020 Nov 12, 2020
424B4 Prospectus Nov 16, 2020 —
EFFECT Filing Nov 12, 2020 —
CORRESP Letter to the SEC Nov 10, 2020 —
CORRESP Letter to the SEC Nov 10, 2020 —
S-1/A Amended registration statement Nov 10, 2020 —
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report Nov 3, 2020 Nov 3, 2020
UPLOAD Letter from the SEC Oct 22, 2020 —
S-1 Registration statement Oct 16, 2020 —
8-K Current report
Results of operations
Oct 14, 2020 Oct 14, 2020
8-K Current report
Regulation FD disclosure
Sep 15, 2020 Sep 15, 2020
8-K Current report
Officer or director change
Aug 24, 2020 Aug 18, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Aug 10, 2020 Aug 10, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Jul 20, 2020 Jul 15, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
10-K/A Amended annual report Apr 29, 2020 Dec 31, 2019
8-K Current report
Results of operations
Apr 8, 2020 Apr 8, 2020
8-K Current report
Material agreement
Mar 30, 2020 Mar 26, 2020
8-K Current report
Officer or director change
Mar 16, 2020 Mar 10, 2020
10-K Annual report Mar 9, 2020 Dec 31, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Mar 9, 2020 Mar 9, 2020
8-K Current report
Material agreement
Feb 19, 2020 Feb 14, 2020
8-K Current report
Results of operations
Jan 13, 2020 Jan 13, 2020
8-K Current report
Regulation FD disclosure
Dec 6, 2019 Dec 6, 2019
424B5 Prospectus supplement Nov 22, 2019 —
8-K Current report
Material agreement, Other events
Nov 22, 2019 Nov 19, 2019
424B5 Prospectus supplement Nov 19, 2019 —
8-K Current report
Material agreement
Nov 15, 2019 Nov 12, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
EFFECT Filing Sep 23, 2019 —
CORRESP Letter to the SEC Sep 19, 2019 —
CORRESP Letter to the SEC Sep 16, 2019 —
S-3/A Filing Sep 16, 2019 —
UPLOAD Letter from the SEC Sep 10, 2019 —
S-3 Shelf registration Sep 4, 2019 —
8-K Current report
Unregistered share sale
Aug 21, 2019 Aug 16, 2019
SC TO-I/A Filing Aug 19, 2019 —
8-K Current report
Material agreement, Change to shareholder rights, Shareholder vote results, Other events
Aug 19, 2019 Aug 19, 2019
SC TO-I/A Filing Aug 9, 2019 —
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2019 Aug 9, 2019
8-K Current report
Material agreement
Aug 8, 2019 Aug 6, 2019
SC TO-I/A Filing Jul 22, 2019 —
DEF 14A Proxy statement Jul 22, 2019 Jul 22, 2019
8-K Current report
Material agreement
Jul 16, 2019 Jul 12, 2019
SC TO-C 8-k Jul 16, 2019 —
SC TO-I Filing Jul 12, 2019 —
PRE 14A Preliminary proxy statement Jul 12, 2019 Jul 12, 2019
8-K Current report
Regulation FD disclosure
May 22, 2019 May 22, 2019
10-Q Quarterly report May 10, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 10, 2019 May 10, 2019
10-K/A Amended annual report Apr 30, 2019 Dec 31, 2018
8-K Current report
Other events
Apr 1, 2019 Apr 1, 2019
8-K Current report
Regulation FD disclosure
Mar 20, 2019 Mar 20, 2019
8-K Current report
Material agreement, New debt
Mar 19, 2019 Mar 13, 2019
10-K Annual report Mar 18, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 18, 2019 Mar 18, 2019
8-K Current report
Material agreement, Agreement ended, New debt, Listing notice, Regulation FD disclosure
Mar 14, 2019 Mar 12, 2019
25-NSE Delisting notice Mar 12, 2019 —
8-K Current report
Listing notice
Mar 12, 2019 Mar 7, 2019
424B3 Prospectus Feb 14, 2019 —
EFFECT Filing Feb 12, 2019 —
8-K Current report
Results of operations, Regulation FD disclosure
Feb 12, 2019 Feb 12, 2019
CT ORDER Filing Feb 11, 2019 —
S-8 Employee stock plan registration Feb 11, 2019 —
POS AM Filing Feb 11, 2019 —
424B3 Prospectus Feb 4, 2019 —
8-K Current report
Other events
Jan 31, 2019 Jan 28, 2019
S-3/A S-3/a amendment no.2 Jan 15, 2019 —
S-3/A Filing Jan 10, 2019 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 7, 2019 Jan 7, 2019
8-K Current report
Listing notice, Other events
Jan 7, 2019 Jan 4, 2019
8-K Current report
Material agreement
Jan 7, 2019 Dec 31, 2018
S-3 Shelf registration Dec 24, 2018 —
25-NSE Delisting notice Dec 14, 2018 —
8-K12G3 Filing Dec 14, 2018 Dec 10, 2018
8-K Current report
Listing notice
Dec 12, 2018 Dec 11, 2018
8-K Current report
Material agreement, Acquisition or sale of assets, Results of operations, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
Dec 11, 2018 Dec 10, 2018
8-K Current report
Shareholder vote results
Dec 10, 2018 Dec 10, 2018
CT ORDER Filing Dec 3, 2018 —
EFFECT Filing Nov 30, 2018 —
424B3 Prospectus Nov 30, 2018 —
S-4/A Filing Nov 30, 2018 —
CORRESP Letter to the SEC Nov 28, 2018 —
CORRESP Letter to the SEC Nov 28, 2018 —
S-4/A Filing Nov 28, 2018 —
UPLOAD Letter from the SEC Nov 28, 2018 —
CORRESP Letter to the SEC Nov 19, 2018 —
S-4/A Filing Nov 19, 2018 —
UPLOAD Letter from the SEC Nov 16, 2018 —
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ORGO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Canton, MA
SEC filer status
Accelerated filer
SEC CIK
1661181
Former names
Avista Healthcare Public Acquisition Corp. (until Dec 10, 2018)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.